|
|
Volumn 25, Issue 10, 2007, Pages 1088-1089
|
|
Why Cabilly must stand [5]
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
RITUXIMAB;
TRASTUZUMAB;
MONOCLONAL ANTIBODY;
BIOTECHNOLOGY;
DRUG INDUSTRY;
DRUG RESEARCH;
FUNDING;
LETTER;
PATENT;
PRIORITY JOURNAL;
PROTECTION;
HUMAN;
INDUSTRY;
LEGAL ASPECT;
NOTE;
ANTIBODIES, MONOCLONAL;
BIOTECHNOLOGY;
HUMANS;
INDUSTRY;
PATENTS AS TOPIC;
|
|
EID: 35148870809
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt1007-1088 Document Type: Letter |
|
Times cited : (1)
|
|
References (0)
|
